Trinity Biotech (TRIB) Return on Capital Employed (2009 - 2024)
Trinity Biotech (TRIB) posted Return on Capital Employed of 31.0% for Q4 2024, down 56.6% sequentially from 19.79% in Q3 2024, and up 2720.0% YoY from 1.1% in Q1 2024.
Trinity Biotech (TRIB) Return on Capital Employed (2009 - 2024) Analysis & Trends
Trinity Biotech has reported Return on Capital Employed for 16 years, with the latest figure at 31.0% in Q4 2024.
- Quarterly Return on Capital Employed rose 2720.0% year-over-year to 31.0% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 31.0% (up 2720.0% YoY) and the FY2025 annual result came in at 42.69%, up 8565.0% from the prior year.
- Return on Capital Employed retreated to 31.0% in Q4 2024 per TRIB's latest filing, from 19.79% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 86.72% in Q2 2021 and troughed at 58.2% in Q4 2023.
- A 5-year average of 5.08% and a median of 5.91% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2021 and 2022: Return on Capital Employed jumped 8204 bps in 2021, then sank 8644 bps in 2022.
- Over 5 years, Return on Capital Employed stood at 19.16% in 2020, then soared by 70 bps to 32.57% in 2021, then plunged by 177 bps to 24.92% in 2022, then slumped by 134 bps to 58.2% in 2023, then surged by 47 bps to 31.0% in 2024.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 31.0%, 19.79%, and 23.09% for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Trinity Biotech | 6.53 Mn | 1.39 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -31.00% |
| Sep 30, 2024 | -19.79% |
| Jun 30, 2024 | -23.09% |
| Mar 31, 2024 | -50.28% |
| Dec 31, 2023 | -58.20% |
| Sep 30, 2023 | -57.08% |
| Jun 30, 2023 | -52.47% |
| Mar 31, 2023 | -29.22% |
| Dec 31, 2022 | -24.92% |
| Sep 30, 2022 | -12.11% |
| Jun 30, 2022 | 0.29% |
| Mar 31, 2022 | 2.42% |
| Dec 31, 2021 | 32.57% |
| Sep 30, 2021 | 72.48% |
| Jun 30, 2021 | 86.72% |
| Mar 31, 2021 | 21.40% |
| Dec 31, 2020 | 19.16% |
| Sep 30, 2020 | 11.64% |
| Jun 30, 2020 | 4.68% |
| Mar 31, 2020 | 5.25% |